0
0
10/14/23 at 5:35pm
Organization
CNBC
Author
Anna Gleason
32 words
0
Comments
Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs.
You are the first to view
https://www.cnbc.com/2023/10/14/obesity-medicine-euphoria-warning-experts-tackle-miracle-drugs.html
Create an account
or login to join the discussion